Facebook Pixel Code

Genzyme files patent infringement suit against DRL

Genzyme, a fully-owned subsidiary of drug major Sanofi, has filed a suit against Dr Reddy?s Laboratories alleging that the Indian drug maker infringed patents of its cancer drug Mozobil on three counts

Genzyme, a fully-owned subsidiary of drug major Sanofi, has filed a suit against Dr Reddy?s Laboratories alleging that the Indian drug maker infringed patents of its cancer drug Mozobil on three counts. Mozobil (plerixafor injection) is a haematopoietic stem cell mobiliser indicated to patients with non-Hodgkin?s lymphoma (blood cancer) and multiple myeloma. In its petition filed in the District Court of Delaware, Genzyme alleged that DRL intimated though a letter that it had submitted an Abbreviated New Drug Application with the USFDA seeking a nod to engage in the commercial manufacture, import, use and sale of 20 mg/ml Plerixafor injection as a generic version of Mobozil.

Get live Share Market updates, Stock Market Quotes, and the latest India News and business news on Financial Express. Download the Financial Express App for the latest finance news.

First published on: 23-09-2013 at 02:57 IST
Market Data
Market Data
Today’s Most Popular Stories ×